Rezolute, Inc. (RZLT)
Last updated: 2026-10-21 07:50:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Rezolute, Inc. (RZLT) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.71, with a market capitalization of $357.87M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.07 to $11.46. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$357.87M | |
$3.66 | |
$21.11 | |
$0.72 | |
$3.70 | |
1.11M | |
1.52M | |
-- | |
$11.46 | |
$1.07 | |
-- | |
-- |
Rezolute, Inc. (RZLT) Latest Closing Stock Price
Rezolute, Inc. (RZLT) last closed at $3.70 as of 2026-10-20 23:31:00, unchanged from the previous close of $3.70.
During the latest regular trading session, RZLT traded between $0.72 and $21.11, with a volume of 1.11M shares. The closing price was near the lower end and near the lower end of its 52-week range.
Rezolute, Inc. (RZLT) 7-Day Stock Price Change
Over the past seven days, Rezolute, Inc. (RZLT) moved from $4.87 to $3.71, representing a decline of 23.92% ($1.17).
The stock traded between $3.37 and $4.91 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1.53 million shares, down versus the previous seven-day period, indicating lower trading activity.
RZLT 52-Week Price Position
Position in Range: 25.4%
RZLT is currently trading at $3.71, placing it 25.4% of the way from its 52-week low of $1.07 to its 52-week high of $11.46. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Rezolute, Inc. (RZLT)?
Rezolute Inc is a late-stage rare disease company focused on developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism. Its main clinical asset, Ersodetug, is a potential treatment for refractory hypoglycemia caused by multiple forms of hyperinsulinism. The company has a single reportable segment, which includes all of its activities as a clinical-stage biopharmaceutical company.
Rezolute, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 58 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Rezolute, Inc. (RZLT) Stock on MEXC
Eligible investors can buy real shares of Rezolute, Inc. (RZLT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Rezolute, Inc. (RZLT) stock price today?
2.Is RZLT stock going up or down today?
3.What is RZLT pre-market price?
4.What is RZLT after-hours price?
5.Is RZLT stock trading now?
6.Where does RZLT sit relative to its 52-week high and low?
7.What sector is Rezolute, Inc. in?
8.What is Rezolute, Inc.'s market capitalization and where is it listed?
9.How is RZLT valued in terms of P/E ratio and EPS?
10.Does Rezolute, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
RZLT Stock Calculator
Estimate the value between RZLT shares and USD.
RZLT Shares to USD
1.00 RZLT shares = 3.705 USD
Calculations are estimates based on the latest available price and are for reference only.


